Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found six records

$314,512.00

May 5, 2025

For-profit organization

Agreement:

Next-Generation Resorbable and Long-Term Hollow/Porous Glass Microspheres for Precision Transarterial Embolization.

Agreement Number:

1030534

Duration: from May 5, 2025 to Aug 3, 2026
Description:

This project aims to develop resorbable hollow/porous/solid glass microspheres for precision transarterial embolization (TAE), with long-term variants as an additional option. Unlike permanent embolic agents, the resorbable radiopaque microspheres provide temporary occlusion, precise imaging, and safe, controlled degradation. Objectives include synthesizing tunable glass microsphere compositions, optimizing their structure for payload and delivery efficiencies, and confirming effectiveness in preclinical models. These versatile, biocompatible microspheres enhance TAE precision, minimize long-term risks for temporary embolization needs, and set a new benchmark in interventional radiology.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Halifax, Nova Scotia, CA B3S 1B3

$2,999,699.00

Feb 22, 2018
Agreement:

208491

Agreement Number:

208491

Duration: from Feb 22, 2018 to Jun 30, 2019
Description:

Design, develop and attain quality approval for manufacture of microspheres

Organization: Atlantic Canada Opportunities Agency
Program Name: Atlantic Innovation Fund (AIF) - II
Location: Halifax, Nova Scotia, CA B3S 1B3

$49,500.00

Dec 12, 2014
Agreement:

204934

Agreement Number:

204934

Duration: from Dec 12, 2014 to Jan 31, 2016
Description:

Engage expertise to oversee the technical design and development of products

Organization: Atlantic Canada Opportunities Agency
Program Name: BDP - Productivity and Business Skills
Location: Halifax, Nova Scotia, CA B3H 0A8

$2,140,000.00

Nov 18, 2014
Agreement:

203172

Agreement Number:

203172

Duration: from Nov 18, 2014 to Mar 31, 2018
Description:

Develop and commercialize next generation medical devices for interventional radiology

Organization: Atlantic Canada Opportunities Agency
Program Name: Atlantic Innovation Fund (AIF) - II
Location: Halifax, Nova Scotia, CA B3H 0A8

$50,000.00

Dec 19, 2012
Agreement:

201899

Agreement Number:

201899

Duration: from Dec 19, 2012 to Mar 31, 2014
Description:

Hire a new CEO to advance the commercialization of the company's medical devices

Organization: Atlantic Canada Opportunities Agency
Program Name: BDP - Productivity and Business Skills
Location: Halifax, Nova Scotia, CA B3H 0A8

$499,975.00

Oct 12, 2012
Agreement:

201431

Agreement Number:

201431

Duration: from Oct 12, 2012 to Oct 31, 2014
Description:

Development of technology to support the treatment of uterine fibroids

Organization: Atlantic Canada Opportunities Agency
Program Name: Business Development Program
Location: Halifax, Nova Scotia, CA B3H 0A8